Hedge Fund Stock Picks & Ticker Coverage
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Seven Corners Capital Management, LLC Scott Klarquist | “Genworth Financial ($GNW) is a diversified financial services holding company whose core value driver is an 80% controlling ownership stake in Enact Holdings ($ACT), a profitable private mortgage insurer. Representing 17.4% of the portfolio, the bullish thesis is rooted in a classic sum-of-the-parts market inefficiency where Genworth's equity trades at a substantial 18% discount to the look-through market value of its underlying Enact shares alone, while assigning zero value to its other operating assets. From a balance sheet and valuation perspective, each Genworth share corresponds to approximately 0.292 shares of Enact, representing $14.30 of market value compared to Genworth's trading price below $10.50. While the holding company carries $540 million of net debt, this liability is anticipated to be entirely eliminated by an expected $750 million legal judgment recovery in the UK payment protection insurance litigation. Furthermore, regulatory de-stacking of the Life and Annuity operations from legacy Long Term Care liabilities could unlock trapped dividend cash flows. Key catalysts include the resolution of Santander's litigation appeal within 12 to 18 months, sustained share buybacks, and an eventual corporate separation or spin-off of Enact. Critical risks center on adverse appellate rulings in the UK litigation and potential regulatory roadblocks preventing corporate restructuring.” | BULL | Q2 2026 Sep 8, 2026 | View Pitch |
Seven Corners Capital Management, LLC Scott Klarquist | “Genworth Financial continued to represent a core value holding, offering indirect ownership of its majority stake in mortgage insurer Enact Holdings at a discount. The market continues to ascribe little to no value to Genworth's life and long-term care businesses, despite meaningful optionality from litigation proceeds and potential restructuring. Share repurchases accelerated following activist pressure, improving per-share value. SCC views GNW as a sum-of-the-parts opportunity with multiple paths to value realization. BSD Analysis: Genworth is a balance-sheet and legacy-liability story, not a growth narrative. The moat—if it exists—is regulatory complexity that traps competitors and capital alike. Long-term care insurance liabilities dominate investor perception and valuation. Execution progress matters, but credibility has been eroded over years of restructuring and deferrals. Asset value exists, yet realization is slow and politically constrained. The bull case is gradual liability runoff and capital release that the market hasn't fully priced in. The bear case is adverse actuarial surprises resetting the story again. Genworth is a patience test where time, not growth, is the investment thesis.” | BULL | Q4 2025 Jan 16, 2026 | View Pitch |
Seven Corners Capital Management, LLC Scott Klarquist | “GNW continues to represent a discounted way to gain indirect exposure to its 81% owned mortgage insurance subsidiary, Enact Holdings, while receiving a free option on its legacy long-term care and life & annuity businesses. The stock traded at a persistent sum-of-the-parts discount of roughly 20%, despite the market ascribing zero value to non-mortgage assets. SCC's thesis centers on an eventual separation or restructuring that would unlock trapped value, particularly if regulatory constraints around the Life & Annuity business are eased. Management has repurchased approximately $590 million of stock at attractive prices since 2022, materially shrinking the share count. Activist pressure and governance reforms remain central to the long-term upside case. BSD Analysis: Genworth is a classic “sum-of-the-parts with baggage” story, where long-term care insurance dominates both the risk and the upside. The company's legacy LTC block is shrinking but still highly sensitive to assumptions around morbidity, lapse rates, and premium approvals, which makes quarterly results volatile and investor sentiment fragile. The upside comes from steady progress on rate increases and claims management, which can meaningfully improve capital adequacy over time. Meanwhile, the mortgage insurance business provides a counterbalance, throwing off capital and benefiting from strong credit quality and conservative underwriting. Genworth's valuation reflects deep skepticism that the LTC overhang ever truly clears, even as fundamentals slowly improve. Management's job is less about growth and more about risk runoff, capital discipline, and regulatory execution. If LTC outcomes continue to trend better than feared, the stock offers asymmetric upside relative to the depressed expectations baked in today.” | BULL | Q2 2025 Jul 18, 2025 | View Pitch |
Seven Corners Capital Management, LLC Scott Klarquist | “Genworth trades at a 15% discount to its enterprise value based solely on its majority stake in Enact Holdings. Unlocking value relies on separating Enact and restructuring its Life & Annuity operations away from long-term care liabilities.” | BULL | Q4 2024 Dec 31, 2024 | View Pitch |
Seven Corners Capital Management, LLC Scott Klarquist | “Genworth Financial trades at a major sum-of-the-parts discount where its 81.6% stake in Enact Holdings is valued higher than Genworth's entire market capitalization. Long-term value creation depends on separating the Enact stake and executing an operational de-stacking of its life and annuity business.” | BULL | Q4 2023 Dec 31, 2023 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.